Vsevolod Y Polotsky Selected Research

Atherosclerotic Plaque (Atheroma)

7/2013	Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4.
4/2010	Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice.
1/2008	Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vsevolod Y Polotsky Research Topics

Disease

39	Hypoxia (Hypoxemia) 12/2022 - 07/2003
29	Obesity 12/2023 - 07/2003
21	Sleep Apnea Syndromes (Sleep Apnea) 01/2024 - 11/2005
20	Obstructive Sleep Apnea 12/2023 - 02/2007
15	Insulin Resistance 12/2023 - 07/2003
10	Inflammation (Inflammations) 01/2022 - 10/2007
9	Atherosclerosis 08/2013 - 02/2007
8	Airway Obstruction (Choking) 12/2023 - 05/2014
8	Sleep Deprivation 03/2023 - 11/2005
7	Apnea 01/2023 - 02/2009
6	Glucose Intolerance 12/2023 - 11/2011
6	Hypoventilation 11/2023 - 01/2018
6	Body Weight (Weight, Body) 01/2022 - 09/2011
5	Hyperglycemia 12/2023 - 04/2007
5	Hypertension (High Blood Pressure) 12/2023 - 01/2015
5	Hyperlipidemias (Hyperlipidemia) 02/2013 - 09/2005
4	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 05/2014
4	Dyslipidemias (Dyslipidemia) 04/2011 - 06/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2016 - 11/2005
3	Morbid Obesity 01/2016 - 05/2014
3	Fibrosis (Cirrhosis) 01/2016 - 01/2012
3	Non-alcoholic Fatty Liver Disease 10/2015 - 01/2009
3	Atherosclerotic Plaque (Atheroma) 07/2013 - 01/2008
2	Obesity Hypoventilation Syndrome (Pickwickian Syndrome) 01/2023 - 01/2022
2	Hypercapnia 01/2023 - 11/2016
2	Respiratory Hypersensitivity 01/2022 - 01/2019
2	Weight Loss (Weight Reduction) 01/2019 - 09/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2016 - 08/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 10/2015
2	Lung Injury 05/2013 - 03/2010
2	Hypertriglyceridemia 08/2012 - 05/2006
2	Fatty Liver 02/2009 - 11/2005
2	Hypercholesterolemia 10/2007 - 05/2006
1	Nervous System Diseases (Neurological Disorders) 03/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023
1	Respiratory Acidosis 01/2023
1	Weight Gain 01/2023
1	Central Sleep Apnea (Central Sleep Apnea Syndrome) 02/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Infections 11/2021
1	Opiate Overdose 01/2021

Drug/Important Bio-Agent (IBA)

27	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 07/2003
25	LeptinIBA 12/2023 - 10/2003
14	Triglycerides (Triacylglycerol)IBA 01/2023 - 04/2007
11	Insulin (Novolin)FDA Link 01/2023 - 10/2003
10	LipidsIBA 01/2017 - 09/2005
9	Oxygen (Dioxygen)IBA 01/2021 - 02/2009
9	CholesterolIBA 03/2012 - 09/2005
8	EnzymesIBA 02/2024 - 06/2007
8	Lipoproteins (Lipoprotein)IBA 01/2018 - 06/2007
6	Blood Glucose (Blood Sugar)IBA 12/2023 - 10/2003
6	Leptin ReceptorsIBA 12/2023 - 09/2011
6	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2019 - 11/2008
6	Nonesterified Fatty Acids (NEFA)IBA 01/2017 - 10/2010
5	Biomarkers (Surrogate Marker)IBA 03/2017 - 08/2011
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 10/2010
4	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 07/2013 - 03/2012
3	Opioid Analgesics (Opioids)IBA 01/2023 - 10/2020
3	Designer DrugsIBA 06/2021 - 01/2018
3	Hormones (Hormone)IBA 10/2019 - 10/2010
3	CatecholaminesIBA 04/2017 - 11/2014
3	C-Reactive ProteinIBA 06/2016 - 02/2009
3	Apolipoproteins E (ApoE)IBA 07/2013 - 01/2008
3	LDL CholesterolIBA 02/2013 - 06/2007
3	Transcription Factors (Transcription Factor)IBA 01/2012 - 10/2007
3	Hypoxia-Inducible Factor 1IBA 01/2012 - 04/2010
3	stearoyl-coenzyme A (stearoyl-CoA)IBA 04/2010 - 06/2007
2	Liver GlycogenIBA 02/2024 - 10/2013
2	Serotonin (5 Hydroxytryptamine)IBA 01/2024 - 01/2022
2	GlycogenIBA 12/2023 - 04/2007
2	Dimenhydrinate (DMH)FDA LinkGeneric 11/2023 - 11/2021
2	KetonesIBA 01/2023 - 08/2012
2	Morphine (MS Contin)FDA LinkGeneric 01/2023 - 10/2020
2	Small Interfering RNA (siRNA)IBA 12/2022 - 11/2019
2	LigandsIBA 06/2021 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 11/2016
2	CollagenIBA 01/2016 - 10/2015
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2014 - 07/2003
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2014 - 08/2012
2	VLDL CholesterolIBA 07/2013 - 11/2008
2	Proteins (Proteins, Gene)FDA Link 05/2013 - 01/2007
2	Antisense OligonucleotidesIBA 01/2012 - 11/2008
2	CytokinesIBA 09/2011 - 07/2003
2	Interleukin-6 (Interleukin 6)IBA 09/2011 - 11/2005
2	Sterol Regulatory Element Binding ProteinsIBA 10/2007 - 05/2006
1	Insulin ReceptorIBA 12/2023
1	Transient Receptor Potential ChannelsIBA 12/2023
1	Oxytocin (Pitocin)FDA LinkGeneric 12/2023
1	SteroidsIBA 03/2023
1	GasesIBA 03/2023
1	Insulin-Like PeptidesIBA 01/2023
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2022

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2008
5	Bariatric Surgery 01/2019 - 02/2009
4	Continuous Positive Airway Pressure 01/2018 - 08/2011
3	Denervation 12/2023 - 10/2014
3	Drug Therapy (Chemotherapy) 01/2021 - 05/2019
2	Analgesia 01/2023 - 10/2020
1	Ketogenic Diet 01/2023